These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10089065)

  • 1. A complex translocation involving chromosomes 2, 9 and 22 in a patient with chronic myeloid leukemia.
    Patel RK; Trivedi AH; Roy SK; Bhachech SH; Bakshi SR; Bhatavdekar JM; Desai CJ; Patel KM; Shah PM
    J Exp Clin Cancer Res; 1998 Dec; 17(4):443-4. PubMed ID: 10089065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
    [No Abstract]   [Full Text] [Related]  

  • 3. Poor prognosis chronic myeloid leukemia with a complex variant Philadelphia translocation, t(9;10;22)(q34;q24;q11).
    Buda G; Orciuolo E; Cecconi N; Galimberti S; Cervetti G; Petrini M
    Leuk Res; 2007 Dec; 31(12):1765-6. PubMed ID: 17320954
    [No Abstract]   [Full Text] [Related]  

  • 4. Simultaneous occurrence of t(9;22)(q34;q11.2) and t(16;16)(p13;q22) in a patient with chronic myeloid leukemia in blastic phase.
    Zámecníkova A; Al Bahar S; Ramesh P
    Cancer Genet Cytogenet; 2008 Jun; 183(2):109-13. PubMed ID: 18503829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemia.
    Buda G; Orciuolo E; Galimberti S; Benedetti E; Caracciolo F; Cervetti G; Carulli G; Papineschi F; Petrini M
    Leuk Res; 2008 Jan; 32(1):192-4. PubMed ID: 17391755
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of cytogenetic features in the patients with chronic myeloid leukemia].
    Shen JK; Zhang GS; Xiao L
    Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):431-2. PubMed ID: 14653141
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorescence in situ hybridization dissection of a chronic myeloid leukemia case bearing the apparently balanced translocations (9;22)(q34;q11.2) and (11;11)(p15;q13).
    Malvestiti F; Colombo D; Perego D; Rodeschini O; Finelli P; Larizza L; Giardino D
    Cancer Genet Cytogenet; 2009 Jan; 188(1):42-7. PubMed ID: 19061779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome.
    Zagaria A; Anelli L; Albano F; Storlazzi CT; Liso A; Roberti MG; Buquicchio C; Liso V; Rocchi M; Specchia G
    Cancer Genet Cytogenet; 2004 Apr; 150(1):81-5. PubMed ID: 15041230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.
    Al-Achkar W; Wafa A; Nweder MS
    J Exp Clin Cancer Res; 2007 Sep; 26(3):411-5. PubMed ID: 17987804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic myeloid leukemia with a novel four-way t(6;13;9;22)(p21;q32;q34;q11.2) successfully treated with imatinib mesylate.
    Kubota Y; Waki M
    Cancer Genet Cytogenet; 2010 Sep; 201(2):135-6. PubMed ID: 20682400
    [No Abstract]   [Full Text] [Related]  

  • 11. Philadelphia chromosome of a constitutional der(22)t(Y;22)(q11.2;p11) with a variant t(1;9;22)(p36;q34;q11) in a case of chronic myelogenous leukemia.
    Buijs A; Terhal PA; Thunnissen PL
    Cancer Genet Cytogenet; 2006 Jul; 168(1):80-2. PubMed ID: 16772126
    [No Abstract]   [Full Text] [Related]  

  • 12. Complex translocation t(6;9;22)(p21.1;q34;q11) at diagnosis is a therapy resistance index in chronic myeloid leukaemia.
    Orciuolo E; Buda G; Galimberti S; Cervetti G; Cecconi N; Papineschi F; Petrini M
    Leuk Res; 2008 Jan; 32(1):190-1. PubMed ID: 17418404
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolated myelosarcoma development in an adolescent chronic myeloid leukemia patient with t(9;22)(q34;q11.2), +8, +14, +21, and der(1)(p36).
    Oren H; Yilmaz S; Sercan Z; Demircioğlu F; Yüksel E; Irken G
    Cancer Genet Cytogenet; 2008 Apr; 182(1):43-5. PubMed ID: 18328950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel complex t(V;9;22) rearrangements in three cases with chronic myeloid leukemia and a rare translocation in a case with classical Philadelphia chromosome.
    Mkrtchyan H; Ghazaryan S; Avetisyan G; Hovhannisyan A; Muradyan L; Daghbashyan S; Karst C; Gross M; Hinreiner S; Aroutiounian R; Liehr T
    Oncol Rep; 2008 Jul; 20(1):99-104. PubMed ID: 18575724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-way Philadelphia variant t(9;22;14)(q34;q11.2;p11) in chronic myeloid leukemia.
    Park TS; Song J; Lee KA; Kim J; Choi JH; Choi JR; Kim SJ; Min YH
    Cancer Genet Cytogenet; 2009 May; 191(1):55-6. PubMed ID: 19389511
    [No Abstract]   [Full Text] [Related]  

  • 16. Concomitant appearance of trisomy 8 and isochromosome 17q in a Philadelphia-positive clone in a patient with chronic myeloid leukemia in chronic phase: an alarm for changing therapeutic strategy.
    Orciuolo E; Buda G; Galimberti S; Sordi E; Cervetti G; Petrini M
    Cancer Genet Cytogenet; 2007 Sep; 177(2):166-7. PubMed ID: 17854678
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events.
    Gargallo P; Cacchione R; Chena C; Dupont J; Garay G; Riveros D; Larripa I; Slavutsky I
    Cancer Genet Cytogenet; 2005 Aug; 161(1):74-7. PubMed ID: 16080961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A complicated translocation involving five chromosomes (Nos. 9, 11, 12, 21 and 22) in a patient with chronic myelocytic leukemia (CML).
    Abe R; Shiga Y; Ookoshi T; Tanaka T; Maruyama Y
    Int J Hematol; 1991 Dec; 54(6):479-82. PubMed ID: 1793830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myelogenous leukemia as gene activation model in oncology minireview.
    Zámecníková A
    Neoplasma; 2000; 47(5):269-73. PubMed ID: 11130241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.